Phase II Study of Low-dose Paclitaxel and Cisplatin as a Second-line Therapy after 5-Fluorouracil/Platinum Chemotherapy in Gastric Cancer

This study was performed to evaluate the efficacy and toxicity of low-dose paclitaxel/cisplatin chemotherapy in patients with metastatic or recurrent gastric cancer that had failed 5-fluorouracil/platinum-based chemotherapy. Thirty-two patients with documented progression on or within 6 months after...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Keun-Wook, Kim, Jee Hyun, Yun, Tak, Song, Eun Kee, Na, Im il, Shin, Hyunchoon, Oh, So Yeon, Choi, In Sil, Oh, Do-Youn, Kim, Dong-Wan, Im, Seock-Ah, Kim, Tae-You, Lee, Jong Seok, Heo, Dae Seog, Bang, Yung-Jue, Kim, Noe Kyeong
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2007
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694374/
https://www.ncbi.nlm.nih.gov/pubmed/17923737
http://dx.doi.org/10.3346/jkms.2007.22.S.S115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694374/
https://www.ncbi.nlm.nih.gov/pubmed/17923737
http://dx.doi.org/10.3346/jkms.2007.22.S.S115

Ejemplares similares